|
Lung (49)
|
|
Diffuse alveolar damage (DAD)
|
44 (89.79)
|
|
Early DAD
|
14 (28.57)
|
|
Proliferative or organising phase of DAD
|
20 (40.81)
|
|
Late DAD
|
10 (20.40)
|
|
Interstitial pneumonia
|
4 (8.16)
|
|
Lung abscess
|
1 (2.04)
|
|
Pulmonary oedema
|
6 (12.24)
|
|
Microthrombi
|
21 (42.85)
|
|
Hyaline membrane
|
19 (39.77)
|
|
Type II pneumocyte hyperplasia
|
15 (30.61)
|
|
Intra-alveolar hemorrhage
|
12 (24.48)
|
|
Myocardium (51)
|
|
Focal myocardial hypertrophy
|
39 (79.59)
|
|
Interstitial myocarditis
|
2 (4.08)
|
|
Interstitial fibrosis
|
8 (16.32)
|
|
Plasma cell and neutrophilic infiltration
|
6 (12.24)
|
|
Kidney (47)
|
|
Cloudy degeneration of tubules
|
24 (51.06)
|
|
Thyroidisation of tubules
|
7 (14.89)
|
|
Tubular atrophy
|
6 (12.76)
|
|
Glomerular congestion
|
18 (38.29)
|
|
Mesangial proliferation
|
12 (25.53)
|
|
Glomerulosclerosis
|
7 (14.89)
|
|
Interstitial inflammation
|
12 (25.53)
|
|
Hyaline arteriosclerosis
|
9 (19.14)
|
|
Liver (49)
|
|
Hepatic sinusoidal dilatation and congestion
|
29 (59.18)
|
|
Vacuolar degeneration
|
22 (44.89)
|
|
Microvesicular fatty change
|
18 (36.3)
|
|
Cholestasis
|
5 (10.20)
|
|
Lymphocytic infiltration
|
30 (61.22)
|
|
Central venous congestion
|
14 (28.57)
|
|
Spleen (46)
|
|
Sinusoidal congestion
|
22 (47.83)
|
|
Amyloidosis
|
1 (2.17)
|
